Study warns of high Medicare costs for semaglutide even with restrictive CVD definition

If Medicare Part D narrowly defines cardiovascular disease, the majority of patients would remain ineligible while new federal spending could still exceed $10 billion

Arab Health opportunities for UK cannula manufacturer Sterimedix – Lifescience Industry News

A UK based manufacturer, Sterimedix Ltd, are showcasing how they have become a world leader in the development of ophthalmic and aesthetic cannulas, when they

January 30, 2023

Study reveals role of kidneys in high altitude acclimatization

A study from a Mount Royal University physiologist and his team demonstrates the key role of the kidneys in acclimatization to high altitude, and illustrates

December 31, 2024

Driving innovation in respiratory health: Areteia’s 2025 milestones and future goals

During the 43rd J.P. Morgan Annual Healthcare Conference last month, Areteia Therapeutics took centre stage, presenting a detailed review of its achievements in 2024 and

February 5, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.